PhilArchive
open access
Why the Reset Persists: Durability and Failure in Psychedelic-Assisted Therapy
Psychedelic-assisted therapy has produced strong empirical results across depression, anxiety, addiction, and end-of-life distress, but the field’s leading mechanistic model leaves several important questions unanswered. The Relaxed Beliefs Under Psychedelics (REBUS) model, developed by Carhart-Harris and Friston, explains the acute pharmacological action of psychedelics in terms of precision-weighting relaxation within a predictive processing hierarchy. What REBUS does not fully explain is why the therapeutic revision persists after the drug clears the system, why individual responses vary so widely under the same pharmacological conditions, what ego dissolution consists of at the architectural level, how set and setting shape outcomes mechanistically, or why trauma-related conditions respond differently than non-trauma depression. This paper applies the Coherence Engine framework, a general architectural theory of consciousness developed through phenomenological observation and described in full elsewhere (Sowell, 2026), to psychedelic-assisted therapy. The relevant architectural components are summarized and then used to address each of these gaps. The framework extends to addiction through a three-layer model distinguishing identity, behavioral/cognitive, and physiological components, with implications for why different compounds, including ibogaine, work for different addictions. Architectural accounts of OCD, end-of-life anxiety, eating disorders, and the strengthening of fragile identity structures are also developed. The framework does not replace REBUS but provides the architectural context within which REBUS operates, generating nineteen testable predictions that REBUS alone cannot produce. Implications for clinical protocol design, patient selection, integration practice, and conditions under which psychedelic therapy should not proceed are described as hypotheses derived from the architecture.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- One-shotted: psychedelic insights are uniquely intense, meaningful and ineffable#435622
- The Emerging Neurobiology of Psychedelics: Critical Periods, Metaplasticity, and Extracellular Matrix Remodeling.#430968
- Psychedelics, rebirth experiences, and the limits of current research#665363
- The intersection between psychedelics and schizophrenia spectrum disorders: Reevaluating risk and therapeutic potential.#380949
- Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers' task group on psychedelics and related compounds.#1107310
Record · ID 120930
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive